The legacy of Viagra and its effect on the pharmaceutical landscape presents a thorny question for potential backers. Initially a massive drug, competitors have significantly eroded its market dominance, creating difficulties for companies participating to the original patent holder and related formulas. While some firms might benefit from niche… Read More